The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Glycogen Synthase Kinase-3β Haploinsufficiency Mimics the Behavioral and Molecular Effects of Lithium
Open accessAbstract
Lithium is widely used to treat bipolar disorder, but its mechanism of action in this disorder is unknown. Several molecular targets of lithium have been identified, but these putative targets have not been shown to be responsible for the behavioral effects of lithium in vivo. A robust model for the effects of chronic lithium on behavior in mice would greatly facilitate the characterization of lithium action. We describe behaviors in mice that are robustly affected by chronic lithium. Remarkably, these lithium-sensitive behaviors are also observed in mice lacking one copy of the gene encoding glycogen synthase kinase-3 β (Gsk-3 β), a well established direct target of lithium. In addition, chronic lithium induces molecular changes consistent with inhibition of GSK-3 within regions of the brain that are paralleled in Gsk-3 β+/-heterozygous mice. We also show that lithium therapy activates Wnt signaling in vivo, as measured by increased Wnt-dependent gene expression in the amygdala, hippocampus, and hypothalamus. These observations support a central role for GSK-3β in mediating behavioral responses to lithium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ghribi, O., Herman, M. M., Spaulding, N. K., & Savory, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00957.x · Cited by 94
RetractedThe Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,417
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301
Self-citationAssessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 2×
“The FST is a reliable and widely used predictor of antidepressant efficacy and is also abnormal in mice with targeted deletions of the 5-HT1A receptor and the noradrenaline transporter (Cryan et al., 2002).”
BackgroundRequirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393
Self-citationLithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321
Self-citationGSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C. A., Lee, V. M.-Y., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,196
Self-citationNeural and developmental actions of lithium: A unifying hypothesis
Berridge, M. J., Downes, C. P., & Hanley, M. R. (1989) · Cell · doi:10.1016/0092-8674(89)90026-3 · Cited by 1,014
DasGupta, R., & Fuchs, E. (1999) · Development · doi:10.1242/dev.126.20.4557 · Cited by 1,000
(2000) · Cited by 919
GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins
Meijer, L., Skaltsounis, A.-L., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X. P., Vonica, C. A., Brivanlou, A., Dajani, R., et al. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.11.010 · Cited by 808
Mapping Wnt/β-catenin signaling during mouse development and in colorectal tumors
Maretto, S., Cordenonsi, M., Dupont, S., Braghetta, P., Broccoli, V., Hassan, A. B., Volpin, D., Bressan, G. M., & Piccolo, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0434590100 · Cited by 761
Self-citationAxonal Remodeling and Synaptic Differentiation in the Cerebellum Is Regulated by WNT-7a Signaling
Hall, A. C., Lucas, F. R., & Salinas, P. C. (2000) · Cell · doi:10.1016/s0092-8674(00)80689-3 · Cited by 686
Activation of the Wnt Signaling Pathway: A Molecular Mechanism for Lithium Action
Hedgepeth, C. M., Conrad, L. J., Zhang, J., Huang, H.-C., Lee, V. M. Y., & Klein, P. S. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8552 · Cited by 636
Self-citationA common mechanism of action for three mood-stabilizing drugs
Williams, R. S. B., Cheng, L., Mudge, A. W., & Harwood, A. J. (2002) · Nature · doi:10.1038/417292a · Cited by 618
Crawley, J. N., & Paylor, R. (1997) · Hormones and Behavior · doi:10.1006/hbeh.1997.1382 · Cited by 553
Chalecka-Franaszek, E., & Chuang, D.-M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8745 · Cited by 542
Molecular Targets of Lithium Action
Phiel, C. J., & Klein, P. S. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.789 · Cited by 515
Self-citationThe Role of the Extracellular Signal-Regulated Kinase Signaling Pathway in Mood Modulation
Einat, H., Yuan, P., Gould, T. D., Li, J., Du, J., Zhang, L., Manji, H. K., & Chen, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-19-07311.2003 · Cited by 481
Inhibitory Phosphorylation of Glycogen Synthase Kinase-3 (GSK-3) in Response to Lithium
Zhang, F., Phiel, C. J., Spece, L., Gurvich, N., & Klein, P. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212635200 · Cited by 435
Self-citationRegulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium
De Sarno, P., Li, X., & Jope, R. S. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00215-0 · Cited by 434
Peifer, M., Sweeton, D., Casey, M., & Wieschaus, E. (1994) · Development · doi:10.1242/dev.120.2.369 · Cited by 426
The Drosophila Wnt, Wingless, Provides an Essential Signal for Pre- and Postsynaptic Differentiation
Packard, M., Koo, E. S., Gorczyca, M., Sharpe, J., Cumberledge, S., & Budnik, V. (2002) · Cell · doi:10.1016/s0092-8674(02)01047-4 · Cited by 409
Bhat, R. V., Shanley, J., Correll, M. P., Fieles, W. E., Keith, R. A., Scott, C. W., & Lee, C.-M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190297597 · Cited by 366
De Ferrari, G. V., Chacón, M. A., Barría, M. I., Garrido, J. L., Godoy, J. A., Olivares, G., Reyes, A. E., Alvarez, A., Bronfman, M., & Inestrosa, N. C. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001208 · Cited by 332
GBP, an Inhibitor of GSK-3, Is Implicated in Xenopus Development and Oncogenesis
Yost, C., Farr, G. H., Pierce, S. B., Ferkey, D. M., Chen, M. M., & Kimelman, D. (1998) · Cell · doi:10.1016/s0092-8674(00)81208-8 · Cited by 328
Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons
Muñoz-Montaño, J. R., Moreno, F. J., Avila, J., & Dı́az-Nido, J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00688-1 · Cited by 322
Lucas, F. R., Goold, R. G., Gordon-Weeks, P. R., & Salinas, P. C. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.10.1351 · Cited by 301
Goold, R. G., Owen, R., & Gordon-Weeks, P. R. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.19.3373 · Cited by 281
WNT-7a Induces Axonal Remodeling and Increases Synapsin I Levels in Cerebellar Neurons
Lucas, F. R., & Salinas, P. C. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8734 · Cited by 274
Endophenotypes in bipolar disorder
Lenox, R. H., Gould, T. D., & Manji, H. K. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10360 · Cited by 264
Song, L., De Sarno, P., & Jope, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206047200 · Cited by 256
Neurochemical basis of the action of antidepressants on learned helplessness
Sherman, A. D., & Petty, F. (1980) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(80)91005-5 · Cited by 254
Eickholt, B. J., Walsh, F. S., & Doherty, P. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201098 · Cited by 243
Animal models in psychiatry and neurology
Hanin, I., & Usdin, E. (1977) · Cited by 224
Lochhead, P. A., Coghlan, M., Rice, S. Q. J., & Sutherland, C. (2001) · Diabetes · doi:10.2337/diabetes.50.5.937 · Cited by 219
The reliability of the hole-board apparatus
File, S. E., & Wardill, A. G. (1975) · Psychopharmacologia · doi:10.1007/bf00421183 · Cited by 210
Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model
Pérez, M., Hernández, F., Lim, F., Díaz-Nido, J., & Avila, J. (2003) · Journal of Alzheimer's Disease · doi:10.3233/jad-2003-5405 · Cited by 180
beta-Catenin associates with the actin-bundling protein fascin in a noncadherin complex.
Tao, Y. S., Edwards, R. A., Tubb, B., Wang, S., Bryan, J., & McCrea, P. D. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.5.1271 · Cited by 175
Sayas, C. L., Moreno-Flores, M. T., Avila, J., & Wandosell, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37046 · Cited by 172
Valproate Regulates GSK-3-Mediated Axonal Remodeling and Synapsin I Clustering in Developing Neurons
Hall, A. C., Brennan, A., Goold, R. G., Cleverley, K., Lucas, F. R., Gordon-Weeks, P. R., & Salinas, P. C. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1117 · Cited by 166
Lithium and valproic acid: parallels and contrasts in diverse signaling contexts
Gurvich, N. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00299-1 · Cited by 164
York, J. D., Ponder, J. W., & Majerus, P. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.5149 · Cited by 158
Divergent roles of GSK3 and CDK5 in APP processing
Ryder, J. W., Yuan, S., Liu, F., Li, B., Zhou, Y., & Ni, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.014 · Cited by 144
Wnts and TGFβ in synaptogenesis: old friends signalling at new places
Packard, M. C., Mathew, D., & Budnik, V. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1036 · Cited by 125
Regulation of Glycogen Synthase Kinase 3β and Downstream Wnt Signaling by Axin
Hedgepeth, C. M., Deardorff, M. A., Rankin, K., & Klein, P. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7147 · Cited by 118
Self-citationKitamura, Y., Araki, H., & Gomita, Y. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00625-6 · Cited by 107
Behavioral Phenotyping of Transgenic and Knockout Mice
Crawley, J. N. (1999) · CRC Press eBooks · doi:10.1201/9780849333644.pt3 · Cited by 99
Lithium attenuates Drug-induced Hyperactivity in Rats
COX, C., Harrison-Read, P. E., Steinberg, H., & TOMKIEWICZ, M. (1971) · Nature · doi:10.1038/232336a0 · Cited by 91
Nixon, M., Hascoët, M., Bourin, M., & Colombel, M. C. (1994) · Psychopharmacology · doi:10.1007/bf02244752 · Cited by 73
Wood, A. J., Goodwin, G. M., Souza, R. D., & Green, A. R. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90149-8 · Cited by 71
Redrobe, J. P., & Bourin, M. (1999) · Psychopharmacology · doi:10.1007/s002130050846 · Cited by 66
Manji, H. K., Chen, G., Hsiao, J., Risby, E. D., Masana, M. I., & Potter, W. Z. (1996) · PubMed · Cited by 66
Lithium and ?-methyl-p-tyrosine prevent ?manic? activity in rodents
Davies, C., Sanger, D. J., Steinberg, H., TOMKIEWICZ, M., & U'Prichard, D. C. (1974) · Psychopharmacology · doi:10.1007/bf00421808 · Cited by 64
Wnt factors in axonal remodelling and synaptogenesis.
Salinas, P. C. (1999) · PubMed · Cited by 62
Wegener, G., Bandpey, Z., Heiberg, I. L., Mørk, A., & Rosenberg, R. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1341-6 · Cited by 61
Behavioral characteristics of SART-Stressed mice in the forced swim test and drug action
Hata, T., Itoh, E., & Nishikawa, H. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00057-4 · Cited by 41
Wnts as Retrograde Signals for Axon and Growth Cone Differentiation
Burden, S. J. (2000) · Cell · doi:10.1016/s0092-8674(00)80685-6 · Cited by 37
The effect of lithium administration in animal models of depression: a short review
Redrobe, J. P., & Bourin, M. (1999) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1999.tb00348.x · Cited by 32
Effect of lithium and other drugs on the amphetamine chlordiazepoxide hyperactivity in mice
Poitou, P., Boulu, R. G., & Bohuon, C. (1975) · Cellular and Molecular Life Sciences · doi:10.1007/bf01924701 · Cited by 31
Reversal of learned helplessness by chronic lithium treatment at a prophylactic level.
Ms, F., & Teixeira, N. A. A. (1993) · PubMed · Cited by 19
Lithium attenuates hypokinesia induced by immobilization stress in rats
Kofman, O., Levin, U., & Alpert, C. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(95)00198-0 · Cited by 12
Cited by
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Beurel, E., Grieco, S. F., & Jope, R. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.016 · Cited by 1,768
Martin, M., Rehani, K., Jope, R. S., & Michalek, S. M. (2005) · Nature Immunology · doi:10.1038/ni1221 · Cited by 1,080
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 522
Metadata
- Authors
- O'Brien, W. T., Harper, A. D., Jové, F., Woodgett, J. R., Maretto, S., Piccolo, S., & Klein, P. S.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2004-07-28
- Volume
- 24
- Issue
- 30
- Pages
- 6791-6798
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2133627256
- Cited by
- 415
- References
- 63
- FWCI
- 13.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.